Summary and recommendations.

The article reports that the World Health Organization Expert Committee made a number of recommendations in the various specific areas of work in quality assurance discussed during its 39th meeting. The area covered by this Expert Committee are extensive and range from GMP, regulatory guidance texts, as well as the areas of counterfeit and substandard medicines. The Committee worked on the quality control specifications for those medicines used in the treatment of large populations for which international quality requirements are often not publicly available.